3Forouhi NG,Ye Z,Rickard AP,et al.Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes:results from the European Prospective Investigation into Cancer(EPIC)-Norfolk cohort and updated meta-analysis of prospective studie[J].Diabetologia,2012,55(8):2173-2182.
4Brownlee MI.Biochemistry and molecular cellbiology of diabetic complicatios[J].Nature,2011,414(6865):813-861.
5Kim SM,Choi HJ,Lee JP,et al.Prevalence of vitamin d deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney disease[J].Ren Nutr,2014,24(1):20-25.
6Heaney RP.Vitamin D and kidney disease[J].Clin J Am Soc Nephro,2008,3(5):1555-1560.
7Palmer SC,Strippoli GF.Proteinuria:does vitamin D treatment improve outcomes in CKD?[J].Nat Rev Nephrol,2008,9(11):638-640.
8Cavalier E,Thervet E,Courbebaisse M.Vitamin D and kidney diseases[J].Presse Med,2013,42(10):1391-1397.
9Vaidya A,Williams JS.The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension,kidney disease,and diabetes[J].Metabolism,2012,61(4):450-458.
10Kim MJ,Frankel AH,Donaldson M,et al.Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition[J].Kidney Int,2011,80(8):851-860.
